Publications

Publications

320 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Period from
to

Enter a start and/or end date here, using the following format: DD-MM-YYYY.

You can select a specific type of a publication you are looking for, such as press releases or speeches

Sort by: Date / Relevance

Asfotase alfa (Strensiq ®) for the treatment of hypophosphatasia (HPP)

Zorginstituut Nederland has completed its assessment whether asfotase alfa (Strensiq®) is interchangeable with a ...

Report | 19-03-2020

Olaparib (Lynparza®) for the maintenance treatment of adult patients with carcinoma of the ovaries, tubes or peritoneum

Zorginstituut Nederland has completed its assessment whether olaparib (Lynparza®) as a monotherapy for the maintenance treatment ...

Report | 19-03-2020

Trientine tetrahydrochloride (Cuprior®) the treatment of Wilson’s disease

Zorginstituut Nederland has completed its assessment whether trientine tetrahydrochloride (Cuprior®) is interchangeable with a ...

Report | 19-03-2020

Hydroquinine (Inhibin®) for patients with nocturnal muscle cramps

Zorginstituut Nederland has assessed whether hydroquinine (Inhibin®) should be included in the medication reimbursement system ...

Report | 04-03-2020

Voretigene neparvovec (Luxturna®) for the treatment of vision loss due to inherited retinal dystrophy with bi-allelic RPE65 mutations

Zorginstituut Nederland has completed its assessment whether voretigene neparvovec (Luxturna®) for the treatment of vision loss ...

Report | 17-02-2020

Emicizumab (Hemlibra®) for the prophylactic treatment of bleeding in patients with severe haemophilia A without inhibitors

Zorginstituut Nederland has completed its assessment whether emicizumab (Hemlibra®) for the prophylactic treatment of bleeding in ...

Report | 17-02-2020

GVS assessment of Bevespi® aerosphere for the treatment of COPD

Zorginstituut Nederland has completed its assessment whether Bevespi® aerosphere for the treatment of COPD, can be included in ...

Report | 27-01-2020

GVS assessment of racecadotril (Hidrasec®) for the treatment of acute diarrhoea in infants (over 3 months of age) and children

The Zorginstituut has completed its assessment whether racecadotril (Hidrasec®) is interchangeable with another product that is ...

Report | 17-12-2019

GVS assessment of a 4 component meningococcal B vaccine (Bexsero®)

Zorginstituut Nederland has completed its assessment whether the product 4 component meningococcal B vaccine (4CMenB) (Bexsero®) ...

Report | 16-12-2019

GVS assessment of hydrocortisone (Alkindi®) for the treatment of adrenal insufficiency

Zorginstituut Nederland has completed its assessment whether hydrocortisone (Alkindi®) can be included in the Medication ...

Report | 10-12-2019